JPWO2023168326A5 - - Google Patents
Info
- Publication number
- JPWO2023168326A5 JPWO2023168326A5 JP2024552169A JP2024552169A JPWO2023168326A5 JP WO2023168326 A5 JPWO2023168326 A5 JP WO2023168326A5 JP 2024552169 A JP2024552169 A JP 2024552169A JP 2024552169 A JP2024552169 A JP 2024552169A JP WO2023168326 A5 JPWO2023168326 A5 JP WO2023168326A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- sequence
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263316140P | 2022-03-03 | 2022-03-03 | |
| US63/316,140 | 2022-03-03 | ||
| PCT/US2023/063559 WO2023168326A2 (en) | 2022-03-03 | 2023-03-02 | Humanized and affinity-matured anti-ceacam1 antibodies and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508963A JP2025508963A (ja) | 2025-04-10 |
| JPWO2023168326A5 true JPWO2023168326A5 (https=) | 2026-03-09 |
| JP2025508963A5 JP2025508963A5 (https=) | 2026-03-09 |
Family
ID=87884376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552169A Pending JP2025508963A (ja) | 2022-03-03 | 2023-03-02 | ヒト化及び親和性成熟抗ｃｅａｃａｍ１抗体及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250388666A1 (https=) |
| EP (1) | EP4486380A2 (https=) |
| JP (1) | JP2025508963A (https=) |
| CN (1) | CN119032103A (https=) |
| AU (1) | AU2023227877A1 (https=) |
| CA (1) | CA3245215A1 (https=) |
| WO (1) | WO2023168326A2 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091163A1 (es) * | 2007-11-01 | 2009-08-09 | Wyeth Corp | Anticuerpos para gdf8 |
| EP2785743B1 (en) * | 2011-12-01 | 2019-08-14 | The Brigham and Women's Hospital, Inc. | Anti-ceacam1 recombinant antibodies for cancer therapy |
| WO2015101996A1 (en) * | 2014-01-02 | 2015-07-09 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Antibodies to ceacam1 and kinase inhibitors for treating braf-mutated cells |
-
2023
- 2023-03-02 JP JP2024552169A patent/JP2025508963A/ja active Pending
- 2023-03-02 EP EP23764120.4A patent/EP4486380A2/en active Pending
- 2023-03-02 AU AU2023227877A patent/AU2023227877A1/en active Pending
- 2023-03-02 WO PCT/US2023/063559 patent/WO2023168326A2/en not_active Ceased
- 2023-03-02 US US18/842,534 patent/US20250388666A1/en active Pending
- 2023-03-02 CN CN202380031369.6A patent/CN119032103A/zh active Pending
- 2023-03-02 CA CA3245215A patent/CA3245215A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI805121B (zh) | 抗ＳＩＲＰα抗體及其用途 | |
| US20230391882A1 (en) | Combination treatment | |
| JP2019116474A5 (https=) | ||
| JP2021534802A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2019527553A5 (https=) | ||
| JP2020508334A5 (https=) | ||
| JP2018510636A5 (https=) | ||
| RU2013142600A (ru) | Белки, связывающие специфический мембранный антиген простаты, и соответствующие композиции и способы | |
| JP2024001073A5 (https=) | ||
| JPWO2021011885A5 (https=) | ||
| JP2021517152A5 (https=) | ||
| IL280487B2 (en) | Anti-mica/b antibodies that block mica/b shedding and methods of use | |
| JP2019512207A5 (https=) | ||
| JP2021523949A5 (https=) | ||
| CN111655287A (zh) | Ildr2拮抗剂及其组合 | |
| JPWO2019175885A5 (https=) | ||
| WO2023222135A9 (en) | A method of treating solid tumor | |
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use | |
| JPWO2023168326A5 (https=) | ||
| JPWO2019219064A5 (https=) | ||
| JPWO2022217019A5 (https=) | ||
| WO2021178253A1 (en) | Anti-cd19 antibodies and methods of using and making thereof | |
| JPWO2020118295A5 (https=) | ||
| JPWO2021141907A5 (https=) |